Neurofilament-rich intraneuronal inclusions exacerbate neurodegenerative sequelae of brain trauma in NFH/LacZ transgenic mice

Experimental Neurology

Volumn 165, Issue 1, 2000, Pages 77-89

  Galvin, James E ^a,b   Nakamura, Michio ^c   McIntosh, Tracy K ^c   Saatman, Kathryn E ^c   Sampathu, Deepak ^b   Raghupathi, Ramesh ^c   Lee, Virginia M Y ^b   Trojanowski, John Q ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Lewy bodies; Neurodegeneration; Neurofilament; Neuronal cytoplasmic inclusions; Parkinson's disease; Transgenic mice; Traumatic brain injury

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; GLIOSIS; IMMUNOHISTOCHEMISTRY; LEWY BODY; MOUSE; NERVE CELL DEGENERATION; NEUROFILAMENT; NEUROLOGICAL COMPLICATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0033826046     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7461     Document Type: Article

References (75)

1. Expression patterns of β-amyloid precursor protein (β-APP) in neural and non-neural human tissues from Alzheimer's disease and control subjects
2. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
3. Trophism, transplantation and animal models of Parkinson's disease
4. Differential localization of MAP2 and tau in mammalian neurons in situ
5. Microtubules in cultured cells; indirect immunofluorescent staining with tubulin antibody
6. Programmed cell death: Does it play a role in Parkinson's disease?
7. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia
8. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxicischemic brain injury
9. Apoptosis suppressor gene bcl-2 expression after traumatic brain injury in rats
10. Delayed, selective neuronal death following experimental cortical impact injury in rats: Possible role in memory deficits
11. Defective axonal transport in a transgenic model of amyotrophic lateral sclerosis
12. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period
13. Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis
14. The neuropathology of Parkinsonism: An overview
15. Chronic Parkinsonism secondary to intravenous injection of meperidine analogs
16. Alzheimer-Parkinson disease overlap: Neuropathology
17. A controlled cortical impact model of traumatic brain injury in the rat
18. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-galactosidase fusion protein
19. Neuropathology of Parkinson's disease
20. Microglial response to amyloid plaques in APPsw transgenic mice
21. Pathobiology of the Lewy body (LB): Studies of purified LBs, monoclonal antibodies and LB-like inclusions in transgenic mouse models
22. Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit
23. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
24. Identification of programmed cell death in situ via specific labeling of nuclear fragmentation
25. The cellular and molecular pathology of Parkinson's disease
26. Molecular pathology of Alzheimer's disease and related disorders
27. Cytoskeletal protein abnormalities in neurodegenerative diseases
28. Antisense and antigene properties of peptide nucleic acid
29. Neurofilament protein mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons
30. Epitopes located in spatially separate domains of each neurofilament subunit are present in the Lewy bodies of Parkinson's disease
31. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites
32. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch
33. Reduced aopoptosis and cytochrome c-mediated activation in mice lacking caspase-9
34. Monoclonal antibodies distinguish several differentially phosphorylated states of the largest rat neurofilament subunits (NF-M and NF-H) and demonstrate their existence in the normal nervous system of adult rats
35. Structural similarities and differences between neurofilament proteins from five different species as revealed by monoclonal antibodies
36. Monoclonal antibodies to gel-excised glial filament protein and their reactivities with other intermediate filament proteins
37. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes
38. Inclusion body formation and dopaminergic loss in α-synuclein transgenic mice: Implications for neurodegenerative disorders
39. A mechanistic analysis of nondisruptive axonal injury: A review
40. The molecular and cellular sequelae of experimental traumatic brain injury: Pathogenic mechanisms
41. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
42. Twofold over expression of human β-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive or neurodegenerative sequelae following experimental brain injury
43. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging
44. Distribution of phosphoneuroprotein 14 (PNP 14) in vertebrates: Its levels as determined by enzyme immunoassay
45. Increased vulnerability of NFH/LacZ transgenic mouse to traumatic brain injury-induced behavioral deficits and cell loss
46. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia
47. Immunohistochemical characterization of alterations in the distribution of amyloid presursor proteins and β-amyloid peptide after experimental brain injury in the rat
48. Pathology and biology of the Lewy body
49. Neurofilament 68 and neurofilament 200 protein levels decrease after traumatic brain injury
50. Cytoskeletal derangements of cortical neuronal processes three hours after traumatic brian injury in rats: An immunofluorescence study
51. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat
52. The neuronal cytoskeleton is at risk following mild, as well as moderate, severity brain injury
53. Plaque-associated neuronal proteins: A recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain
54. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies
55. Cellular and molecular biology of the beta-amyloid precursor protein and Alzheimer's Disease
56. Ubiquitin and microtubule-associated protein tau immunoreactivity each define distinct structures with differing distributions and solubility properties in Alzheimer brain
57. Death-effector filaments: Novel cytoplasmic structures that recruit caspases and trigger apoptosis
58. Brain trauma induces massive hippocampal neuron death linked to a surge in Aβ(1-42) levels in mice overexpressing mutant APP
59. Progressive atrophy and neuronal cell death for one year following experimental brain trauma in the rat
60. A model of parasagittal controlled cortical impact in the mouse: Cognitive and histopathologic effects
61. α-Synuclein in Lewy bodies
62. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
63. Caspases: Enemies within
64. Apoptotic-like changes in Lewy body-associated disorders and normal aging in substantia nigral neurons
65. Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia
66. Oxidative stress, mutant SODI, and neurofilament pathology in transgenic mouse models of human motor neuron disease
67. Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFH/LacZ transgenic mice
68. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions
69. Projections of the LD nucleus of thalamus to the limbic and visual cortices of the rat
70. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles
71. Increased expression of neurofilament subunit NF-L produces morphological alteration that resemble the pathology of human motor neuron disease
72. The Caenorhabditis elegans cel-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease
73. Traumatically induced reactive change as visualized through the use of monoclonal antibodies targeted to neurofilament subunits
74. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury
75. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation